Marcus Wörwag, who holds a doctorate in pharmacy, takes over the family-owned pharmacies which have been founded by his father, company founder Dr. Fritz Wörwag. In 1965, Fritz Wörwag opened the city pharmacy in Stuttgart-Zuffenhausen which laid the foundation for the Wörwag Pharma company.
Prof. Dr. Roderich Thümmel, Head of Advisory Board: “On behalf of the Advisory Board of Wörwag Pharma I would like to thank Dr. Wörwag for his exceptional commitment over the last 18 years. His period of office has been marked by a remarkable growth of sales, lastly more than 210 million euros in 2018. Furthermore Dr. Wörwag has driven the international expansion of the Wörwag Pharma group in Eastern Europe, Russia, as well as Asia and Latin America. The company therefore stands on a very solid ground which will be further developed.”
WÖRWAG Pharma GmbH & Co. KG is a pharmaceutical company with subsidiaries worldwide. The company develops and sells biofactor preparations.
The range of products of WÖRWAG Pharma comprises both prescription preparations and over the counter (OTC) products and food supplements. Most of the products, which are sold exclusively in pharmacies, are used to treat diabetic comorbidities such as neuropathy (nerve damage) as well as cardiovascular and neurological diseases. In 2018, the company with a staff of 900 employees in more than 35 countries achieved sales of more than 210 million euros.
WÖRWAG Pharma is a family-owned company led by Monika Wörwag and Gerhard Mayer. Dr. Fritz Wörwag founded the company in Stuttgart in 1971. Its headquarters are in Böblingen.
WÖRWAG Pharma GmbH & Co. KG
Dr. Beate Rzadtki
Phone: 07031 62 04-338
Fax: 07031 62 04-32